HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NIP regimen

chemotherapy protocol consisting of the vinorelbine (vinblastine/aa) & above cpds; used in treatment of advanced non-small cell lung cancer

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - NIP regimen: 2
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - NIP regimen: 2
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - NIP regimen: 2
Inorganic Chemicals: 9
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        Ifosfamide: 3556
        NIP regimen: 2
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        Ifosfamide: 3556
        NIP regimen: 2
Heterocyclic Compounds: 198

Experts

1.	Dai, Haifeng: 1 article (04/2003)
2.	Liao, Guoqing: 1 article (04/2003)
3.	Liu, Penghui: 1 article (04/2003)
4.	Qu, Yimei: 1 article (04/2003)
5.	Wang, Hongmei: 1 article (04/2003)
6.	Xie, Guoqing: 1 article (04/2003)

Related Diseases

1.	Vomiting 01/01/1999 - "The NIP regimen was well tolerated by most of the patients but nausea/vomiting was noted in 55% of the cycles administered, most of them of grade 1-2 severity. "
2.	Nausea 01/01/1999 - "The NIP regimen was well tolerated by most of the patients but nausea/vomiting was noted in 55% of the cycles administered, most of them of grade 1-2 severity. "
3.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/20/2003 - "To observe the efficacy and safety of navelbine (NVB) combined with ifosfamide (IFO) and cisplatin (DDP) (NIP regimen) and IFO plus DDP (IP regimen) for advanced non-small cell lung cancer (NSCLC). "

Related Drugs and Biologics

1.	Ifosfamide
2.	Cisplatin (Platino)
3.	Vinorelbine (Navelbine)